L&K Biomed Ltd. (KOSDAQ:156100)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacture and Sale of Medical Devices			29.90B	19.77B	15.37B	19.36B	26.57B
Manufacture and Sale of Medical Devices Growth			51.28%	28.59%	-20.58%	-27.16%	-15.16%
Total			29.90B	19.77B	15.37B	19.36B	26.57B
Total Growth			51.28%	28.59%	-20.58%	-27.16%	-15.16%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
USA			21.82B	-	10.29B	13.73B	-
USA Growth			-	-	-25.01%	-	-
South Korea			2.44B	659.84M	2.72B	2.74B	11.14B
South Korea Growth			270.02%	-75.78%	-0.48%	-75.41%	-17.86%
Thailand			2.49B	-	895.19M	-	-
Other			3.15B	-	1.46B	2.69B	-
Other Growth			-	-	-45.76%	-	-
Overseas			-	19.11B	-	-	-
Australia			-	-	-	201.04M	-
Export			-	-	-	-	14.64B
Total			29.90B	19.77B	15.37B	19.36B	25.78B
Total Growth			51.28%	28.59%	-20.58%	-24.91%	-17.71%

Source: S&P Global Market Intelligence.